Advanced Medical Solutions Group’s (AMS) “Buy” Rating Reiterated at Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a research note published on Wednesday, Marketbeat.com reports. Berenberg Bank currently has a GBX 300 ($3.87) price target on the stock.

Advanced Medical Solutions Group Trading Down 3.8 %

Shares of AMS stock opened at GBX 196.80 ($2.54) on Wednesday. The stock’s fifty day moving average is GBX 211.70 and its two-hundred day moving average is GBX 212.12. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The firm has a market capitalization of £424.94 million, a P/E ratio of 38.14, a PEG ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a fifty-two week low of GBX 176.60 ($2.28) and a fifty-two week high of GBX 275.83 ($3.56).

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings data on Thursday, March 20th. The company reported GBX 10.65 ($0.14) earnings per share for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. Research analysts expect that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current fiscal year.

Advanced Medical Solutions Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, May 29th will be issued a GBX 1.83 ($0.02) dividend. The ex-dividend date is Thursday, May 29th. This represents a yield of 0.89%. This is a positive change from Advanced Medical Solutions Group’s previous dividend of $0.77. Advanced Medical Solutions Group’s dividend payout ratio (DPR) is presently 38.76%.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.